Médecins Sans Frontières - 3Qs on ABR

Unique Identifier Code / URN MSB110670

Date taken / Date Recorded 16/11/2021 12:13 PM

Country Unspecified Country

Commissioning section MSF-LEBANON

Photographer / videographer / producer May AbdelSater

Copyright MSF

Usage Rights (MSF) External Media, MSF Publications, Social Media

Formal Consent Copy available no

Editor's rating ★★★★★ (C)

Video format h264 (Main) (avc1 / 0x31637661)

Duration 2m23s

Maximum Size 1080px × 1080px 166.72 MB

Additional Information / Shotlist 3 questions on antibiotic resistance

When does our body stop responding to antibiotics?
If an antibiotic is poorly chosen or taken in the wrong dose or duration, for the wrong infection, the body and the bacteria will be able to adapt to it.
Consequently, bacteria will be exposed to the antibiotic and will develop a defense mechanism, undermining the antibiotic when you need it next time.

How does antibiotic resistance impact our health?
Resistance to an antibiotic does not stay with the bacteria that develops it, but it rather spreads to other bacteria, it creates a problem at community level.
If we don’t implement IPC measures and wash our hands, we can contribute to transmitting the antibiotic resistance amongst bacteria from a person to another.
In a hospital, the bacteria can spread in ICUs and rooms and among patients.
The problem therefore would affect the whole hospital, then the city, then the world.

Is it a threat to global health?
With time, our antibiotic options will become limited
Bacteria will develop resistance against several types of antibiotics, which will require making new ones. When the new antibiotic is misused, bacteria will identify the antibiotic and resist it, and the need for a new antibiotic arises again.
Of course, the process isn’t as easy as it sounds. There isn’t a lot of options. Pharmaceutical companies can’t produce antibiotics on an ongoing and periodic basis.
With time, with the lack of awareness around the risk of antibiotics and their random use for pain relief, like some people do, the problem will worsen, we will reach a dead end
In my experience, we came across a case, where we ran out of options.
how a patient took a treatment for two weeks, he was supposed to continue for another month, but he developed antibiotic resistance, so we couldn’t proceed and we reached the end line.

Special instructions If you would like to know more about the campaign, please don’t hesitate to contact the campaign's manager [email protected]

3Qs on ABR - EN

3Qs on ABR - EN